We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00209833
Recruitment Status : Unknown
Verified September 2005 by Hannover Medical School.
Recruitment status was:  Active, not recruiting
First Posted : September 21, 2005
Last Update Posted : November 18, 2005
University of Ulm
Johann Wolfgang Goethe University Hospital
University Hospital Freiburg
Klinikum Augsburg
Humboldt-Universität zu Berlin
Universitätsklinikum Hamburg-Eppendorf
University Hospital, Ghent
Medizinische Universitätsklinik Tübingen
Klinikum Hanover-Siloah Hospital
Ev. Krankenhaus Essen-Werden
Klinikum Wuppertal GmbH
Information provided by:
Hannover Medical School

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Estimated Study Completion Date : September 2005
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):